Artificial intelligence is reportedly changing the process of drug discovery. The impact of ai on the pharmaceutical industry is being explored in various areas, including biologics development, longevity medicine, and stem cell therapy. The timeframe for significant payoff from ai in the pharmaceutical industry is uncertain, with some projections ranging from the near future to a decade or more.